Merck, 215783-500G, Antimony(III) chloride

Application

Syntheses and characterization of novel antimony (III) and bismuth (III) derivatives containing β-enamino ester along with antimicrobial evaluation, DFT calculation, and cytotoxic study.: This research focuses on the synthesis and characterization of novel antimony(III) chloride derivatives. The study evaluates their antimicrobial properties, conducts Density Functional Theory (DFT) calculations, and assesses cytotoxicity. The findings suggest significant potential for antimony(III) chloride in developing new antimicrobial agents and understanding their biological interactions (Sangwan et al., 2024).

Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany